X

Trial Profile

A Phase II Study of Vorinostat in Patients with Polycythaemia Vera and Essential Thrombocythaemia.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 02 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vorinostat (Primary)
Indications Essential thrombocythaemia; Polycythaemia vera
Focus Therapeutic Use

Most Recent Events

25 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
25 Jun 2017 Results (n=40) investigating association of methylation age with respect to therapeutic response,presented at the 22nd Congress of the European Haematology Association.
09 Dec 2011 Planned end date changed from 1 May 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com